An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Academic Journal of Biosciences | Volume-1 | Issue-07
Outcomes after Foot Surgery in People with a Diabetic Foot Ulcer And a 2 Year Follow-Up
Dr. Mohammad Sazzad Hossain, Dr. Sharif Md. Musa
Published: Dec. 30, 2013 | 134 114
DOI: 10.36347/sajb.2013.v01i07.007
Pages: 381-385
Downloads
Abstract
Background: Diabetic foot ulcers (DFUs) pose a significant challenge, often leading to severe complications such as non-healing wounds and lower extremity amputations. Objective: This study aims to evaluate the outcomes of surgical interventions in patients with DFUs, focusing on wound healing rates, ulcer recurrence, limb salvage, and survival rates over a two-year follow-up period. Methods: A cohort of 300 patients with DFUs was assessed post-surgery. Socio-demographic data were collected, including age, gender, duration of diabetes, and comorbidities. Outcomes were measured based on wound healing, ulcer recurrence, limb salvage, and survival rates. Results: At the two-year follow-up, 70% of patients achieved complete wound healing within 12 months. However, 25% experienced delayed healing, requiring further interventions, while 5% had chronic non-healing wounds linked to poor glycemic control. Ulcer recurrence was noted in 30% of patients, predominantly at the same anatomical site, with higher rates observed in those with peripheral neuropathy and poor glycemic control. Overall, 85% of patients retained their limbs, with 15% necessitating major amputations due to persistent infections. The mortality rate was 10%, primarily associated with cardiovascular complications. Conclusion: Surgical interventions for DFUs are effective in improving wound healing and limb preservation. However, the high rates of ulcer recurrence and associated mortality emphasize the need for continuous monitoring and a multidisciplinary approach to patient management, particularly in high-risk populations. Regular foot care and rehabilitation protocols are essential for improving long-term outcomes in patients with diabetes.